Publications

Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer’s disease: a phase 1b, randomized, double-blind trial

 41
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer’s disease: a phase 1b, randomized, double-blind trial

Tags:

Previous Article

Targeting of stromal states in pancreatic cancer

Next Article

Immune therapy for Alzheimer's?

Related Posts

Inner speech in motor cortex and implications for speech neuroprostheses

Inner speech in motor cortex and implications for speec...

 109

Infraslow histaminergic dynamics govern priming states to gate moment-to-moment memory accessibility

Infraslow histaminergic dynamics govern priming states ...

 47

Human intelligence relates to neural measures of cognitive map formation

Human intelligence relates to neural measures of cognit...

 221